English Polski
Vol 30, No 2 (2024)
Research paper
Published online: 2024-08-13

open access

Page views 215
Article views/downloads 83
Get Citation

Connect on Social Media

Connect on Social Media

Changes in walking abilities measured on a treadmill and in a community outdoor setting in patients with claudication: preliminary results

Anita Kulik1, Ewelina Dušek2, Przemysław Madejski2, Anna Spannbauer34, Piotr Mika2, Jerzy Trzeciak1
Acta Angiologica 2024;30(2):60-68.

Abstract

Background: The aim of the study is to assess changes in walking abilities measured on a treadmill and in a community outdoor setting after 12-week supervised treadmill training in patients with claudication due to peripheral arterial disease.
Material and methods: The study included 36 patients aged 69.94 ± 6.9, randomised into training (n = 21) and control (n = 15) groups. Changes in pain-free walking distance (PFWDTT), maximal walking distance (MWDTT) during the graded treadmill test and the maximal walking distance (MWDGPS), total walking distance (TWDGPS), average walking distance (AWDGPS), walking speed (WSGPS), number of stops (NSGPS) and stop durations (SDGPS) obtained the during community setting outdoor walking were assessed before and after the programme.
Results: Significant results were observed only in the training group. PFWDTT and MWDTT were prolonged by 92% and 97%, respectively (p < 0.05). AWDGPS and SDGPS increased significantly, which was accompanied by a reduction in NSGPS (p < 0.05).
Conclusions: The 12-week, supervised treadmill training improves walking abilities measured on a treadmill, and partially in a community setting outdoor among patients with claudication.

Article available in PDF format

View PDF Download PDF file

References

  1. Frank U, Nikol S, Belch J, et al. ESVM Guideline on peripheral arterial disease. Vasa. 2019; 48(Suppl 102): 1–79.
  2. Golledge J. Update on the pathophysiology and medical treatment of peripheral artery disease. Nat Rev Cardiol. 2022; 19(7): 456–474.
  3. Eid MA, Mehta KS, Goodney PP. Epidemiology of peripheral artery disease. Semin Vasc Surg. 2021; 34(1): 38–46.
  4. Harwood AE, Pymer S, Ingle L, et al. Exercise training for intermittent claudication: a narrative review and summary of guidelines for practitioners. BMJ Open Sport Exerc Med. 2020; 6(1): e000897.
  5. Gardner AW, Skinner JS, Cantwell BW, et al. Progressive vs single-stage treadmill tests for evaluation of claudication. Med Sci Sports Exerc. 1991; 23(4): 402–408.
  6. Montgomery PS, Gardner AW. The clinical utility of a six-minute walk test in peripheral arterial occlusive disease patients. J Am Geriatr Soc. 1998; 46(6): 706–711.
  7. Hiatt WR, Hirsch AT, Regensteiner JG, et al. Clinical trials for claudication. Assessment of exercise performance, functional status, and clinical end points. Vascular Clinical Trialists. Circulation. 1995; 92(3): 614–621.
  8. Gardner AW, Afaq A. Management of lower extremity peripheral arterial disease. J Cardiopulm Rehabil Prev. 2008; 28(6): 349–357.
  9. Treat-Jacobson D, McDermott MM, Bronas UG, et al. American Heart Association Council on Peripheral Vascular Disease; Council on Quality of Care and Outcomes Research; and Council on Cardiovascular and Stroke Nursing. Optimal Exercise Programs for Patients With Peripheral Artery Disease: A Scientific Statement From the American Heart Association. Circulation. 2019; 139(4): e10–e33.
  10. Noury-Desvaux B, Abraham P, Mahé G, et al. The accuracy of a simple, low-cost GPS data logger/receiver to study outdoor human walking in view of health and clinical studies. PLoS One. 2011; 6(9): e23027.
  11. Le Faucheur A, Abraham P, Jaquinandi V, et al. Study of human outdoor walking with a low-cost GPS and simple spreadsheet analysis. Med Sci Sports Exerc. 2007; 39(9): 1570–1578.
  12. Kulik A, Rosłoniec E, Madejski P, et al. Outdoor walking test with a global positioning system device as an additional tool for functional assessment of older women. J Aging Phys Act. 2021; 29(4): 620–625.
  13. Gernigon M, Le Faucheur A, Fradin D, et al. Global positioning system use in the community to evaluate improvements in walking after revascularization: a prospective multicenter study with 6-month follow-up in patients with peripheral arterial disease. Medicine (Baltimore). 2015; 94(18): e838.
  14. Tew G, Copeland R, Le Faucheur A, et al. Feasibility and validity of self-reported walking capacity in patients with intermittent claudication. J Vasc Surg. 2013; 57(5): 1227–1234.
  15. Klonizakis M, Bianchi SM, Gernigon M, et al. Real-life adaptations in walking patterns in patients with established peripheral arterial disease assessed using a global positioning system in the community: a cohort study. Clin Physiol Funct Imaging. 2018; 38(5): 889–894.
  16. Gernigon M, Le Faucheur A, Noury-Desvaux B, et al. Post-GPS Study Coinvestigators Group. Applicability of global positioning system for the assessment of walking ability in patients with arterial claudication. J Vasc Surg. 2014; 60(4): 973–981.e1.
  17. Le Faucheur A, Abraham P, Jaquinandi V, et al. Measurement of walking distance and speed in patients with peripheral arterial disease: a novel method using a global positioning system. Circulation. 2008; 117(7): 897–904.
  18. Le Faucheur A, Noury-Desvaux B, Mahé G, et al. Variability and short-term determinants of walking capacity in patients with intermittent claudication. J Vasc Surg. 2010; 51(4): 886–892.
  19. Créange A, Serre I, Levasseur M, et al. Réseau SINDEFI-SEP. Walking capacities in multiple sclerosis measured by global positioning system odometer. Mult Scler. 2007; 13(2): 220–223.
  20. Evans CC, Hanke TA, Zielke D, et al. Monitoring community mobility with global positioning system technology after a stroke: a case study. J Neurol Phys Ther. 2012; 36(2): 68–78.
  21. Wevers LEG, Kwakkel G, van de Port IGL. Is outdoor use of the six-minute walk test with a global positioning system in stroke patients' own neighbourhoods reproducible and valid? J Rehabil Med. 2011; 43(11): 1027–1031.
  22. Bostelmann R, Schneller S, Cornelius JF, et al. A new possibility to assess the perioperative walking capacity using a global positioning system in neurosurgical spine patients: a feasibility study. Eur Spine J. 2016; 25(3): 963–968.
  23. Barzilay Y, Noam S, Meir L, et al. Assessing the outcomes of spine surgery using global positioning systems. Spine (Phila Pa 1976). 2011; 36(4): E263–E267.
  24. Gernigon M, Fouasson-Chailloux A, Colas-Ribas C, et al. Test-retest Reliability of GPS derived Measurements in Patients with Claudication. Eur J Vasc Endovasc Surg. 2015; 50(5): 623–629.
  25. Abraham P, Noury-Desvaux B, Gernigon M, et al. The inter- and intra-unit variability of a low-cost GPS data logger/receiver to study human outdoor walking in view of health and clinical studies. PLoS One. 2012; 7(2): e31338.
  26. Norgren L, Hiatt WR, Dormandy JA, et al. TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007; 45 Suppl S: S5–67.
  27. Gardner AW, Poehlman ET. Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis. JAMA. 1995; 274(12): 975–980.
  28. Parmenter BJ, Raymond J, Dinnen P, et al. A systematic review of randomized controlled trials: Walking versus alternative exercise prescription as treatment for intermittent claudication. Atherosclerosis. 2011; 218(1): 1–12.
  29. Rümenapf G, Morbach S, Schmidt A, et al. Intermittent Claudication and Asymptomatic Peripheral Arterial Disease. Dtsch Arztebl Int. 2020; 117(11): 188–193.
  30. Hiatt WR, Rogers RK, Brass EP. The treadmill is a better functional test than the 6-minute walk test in therapeutic trials of patients with peripheral artery disease. Circulation. 2014; 130(1): 69–78.
  31. Mays RJ, Regensteiner JG. Exercise therapy for claudication: latest advances. Curr Treat Options Cardiovasc Med. 2013; 15(2): 188–199.
  32. Mika P, Spannbauer A, Cencora A. Effect of familiarization to treadmill walking on gait profile and walking distance in subjects with claudication. Pielęgniarstwo Chirurgiczne i Angiologiczne/Surgical and Vascular Nursing. 2009; 2: 65–69.
  33. Schmidt SAJ, Lo S, Hollestein LM. Research Techniques Made Simple: Sample Size Estimation and Power Calculation. J Invest Dermatol. 2018; 138(8): 1678–1682.
  34. Abaraogu UO, Dall PM, Brittenden J, et al. Efficacy and Feasibility of Pain management and Patient Education for Physical Activity in Intermittent claudication (PrEPAID): protocol for a randomised controlled trial. Trials. 2019; 20(1): 222.
  35. Bulińska K, Kropielnicka K, Jasiński T, et al. Nordic pole walking improves walking capacity in patients with intermittent claudication: a randomized controlled trial. Disabil Rehabil. 2016; 38(13): 1318–1324.
  36. Rosłoniec E, Więcek M, Bawelski M, et al. Effects of nordic pole walking on oxidative stress and walking abilities in patients with intermittent claudication. Atherosclerosis. 2016; 252: e188.
  37. Kruidenier LM, Nicolaï SPA, Willigendael EM, et al. Functional claudication distance: a reliable and valid measurement to assess functional limitation in patients with intermittent claudication. BMC Cardiovasc Disord. 2009; 9: 9.
  38. Gardner AW. Dissipation of claudication pain after walking: implications for endurance training. Med Sci Sports Exerc. 1993; 25(8): 904–910.
  39. Hersant J, Ramondou P, Picquet J, et al. Calf and non-calf hemodynamic recovery in patients with arterial claudication: Implication for exercise training. Microvasc Res. 2021; 135: 104143.
  40. Harwood AE, Cayton T, Sarvanandan R, et al. A Review of the Potential Local Mechanisms by Which Exercise Improves Functional Outcomes in Intermittent Claudication. Ann Vasc Surg. 2016; 30: 312–320.
  41. Parmenter BJ, Raymond J, Fiatarone Singh MA. The effect of exercise on haemodynamics in intermittent claudication: a systematic review of randomized controlled trials. Sports Med. 2010; 40(5): 433–447.
  42. Khambati H, Boles K, Jetty P. Google Maps offers a new way to evaluate claudication. J Vasc Surg. 2017; 65(5): 1467–1472.